In Brief: Roche European PCR patent:
This article was originally published in The Gray Sheet
Roche European PCR patent: Hoffman-La Roche expects to receive a European patent within the next six months covering enzymes used in the company's polymerase chain reaction gene amplification technology. At a Nov. 6 hearing, the European Patent Office accepted Roche's claims for native and recombinant thermostable DNA polymerases, clearing the way for a patent covering "thermostable enzymes having DNA polymerase activity from any species of bacteria such as Taq DNA polymerase from Thermus aquaticus," the company says...
You may also be interested in...
The maker of prestige-inspired cosmetics at value prices follows its TikTok viral success by teaming with Kathleen Belsten, aka Loserfruit, the second most-followed female gamer on the Amazon-owned livestreaming platform Twitch.
As distribution of Regeneron’s monoclonal antibody treatment for coronavirus begins, OWS officials worry about provider confusion with Lilly’s product due to differences in preparation and administration.
Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things.